Concepedia

Nicholas C. Richardson

NC

6

Publications

263

Citations

6

H-Index

2014

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Albany Medical Center Hospital

Nicholas C. Richardson is an author at Center for Drug Evaluation and Research specializing in oncology, medicine, and pathology.

ORCID

Top concepts

Publications per year

2014–2023

6

Publications

6

The saga of PI3K inhibitors in haematological malignancies: survival is the ultimate safety endpoint

Nicholas C. Richardson, Yvette L. Kasamon, Richard Pazdur et al. · The Lancet Oncology · 2022 · 95 citations

, , +9

FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma

Nicholas C. Richardson, Yvette L. Kasamon, Haiyan Chen et al. · The Oncologist · 2019 · 74 citations · Full text

, , +20

FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphoma

Margret Merino, Yvette L. Kasamon, Hongshan Li et al. · Pediatric Blood & Cancer · 2022 · 33 citations

, , +14

Impact of Total Shoulder Arthroplasty on Golfing Activity

Dean N. Papaliodis, Nicholas C. Richardson, Jason P. Tartaglione et al. · Clinical Journal of Sport Medicine · 2014 · 32 citations

Computer Assisted Cobb Angle Measurements: A novel algorithm

Dean N. Papaliodis, Pierino G. Bonanni, Timothy T. Roberts et al. · The International Journal of Spine Surgery · 2017 · 19 citations · Full text

Rows per page

1–5 of 6